Logo image of ARD

Ardagh Group SA (ARD) Stock Fundamental Analysis

USA - NYSE:ARD -

24.75 USD
+0.63 (+2.61%)
Last: 10/5/2021, 8:42:00 PM
24.72 USD
-0.03 (-0.12%)
After Hours: 10/5/2021, 8:42:00 PM
Fundamental Rating

2

ARD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 22 industry peers in the Containers & Packaging industry. Both the profitability and financial health of ARD have multiple concerns. While showing a medium growth rate, ARD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ARD had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -0.05%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 6.03%
PM (TTM) -0.08%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

There is no outstanding debt for ARD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 0.62, we must say that ARD is in the distress zone and has some risk of bankruptcy.
ARD has a Debt/Equity ratio of -34.80. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -34.8
Debt/FCF N/A
Altman-Z 0.62
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

ARD has a Current Ratio of 2.77. This indicates that ARD is financially healthy and has no problem in meeting its short term obligations.
ARD has a Quick Ratio of 2.30. This indicates that ARD is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.77
Quick Ratio 2.3

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ARD have decreased by -5.39% in the last year.
ARD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.97% yearly.
The Revenue has grown by 9.39% in the past year. This is quite good.
ARD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.05% yearly.
EPS 1Y (TTM)-5.39%
EPS 3Y-6.97%
EPS 5YN/A
EPS Q2Q%21.62%
Revenue 1Y (TTM)9.39%
Revenue growth 3Y-7.83%
Revenue growth 5Y-1.05%
Sales Q2Q%16.69%

3.2 Future

Based on estimates for the next years, ARD will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.94% on average per year.
Based on estimates for the next years, ARD will show a quite strong growth in Revenue. The Revenue will grow by 8.07% on average per year.
EPS Next Y9.94%
EPS Next 2Y14.94%
EPS Next 3Y16.76%
EPS Next 5Y17.94%
Revenue Next Year10.92%
Revenue Next 2Y8.75%
Revenue Next 3Y8.72%
Revenue Next 5Y8.07%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ARD Yearly Revenue VS EstimatesARD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B
ARD Yearly EPS VS EstimatesARD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.66, the valuation of ARD can be described as correct.
When comparing the Price/Earnings ratio of ARD to the average of the S&P500 Index (27.38), we can say ARD is valued slightly cheaper.
The Price/Forward Earnings ratio is 13.01, which indicates a correct valuation of ARD.
When comparing the Price/Forward Earnings ratio of ARD to the average of the S&P500 Index (22.86), we can say ARD is valued slightly cheaper.
Industry RankSector Rank
PE 15.66
Fwd PE 13.01
ARD Price Earnings VS Forward Price EarningsARD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.25
ARD Per share dataARD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ARD's earnings are expected to grow with 16.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.58
PEG (5Y)N/A
EPS Next 2Y14.94%
EPS Next 3Y16.76%

More info and screens

3

5. Dividend

5.1 Amount

ARD has a Yearly Dividend Yield of 2.42%. Purely for dividend investing, there may be better candidates out there.
Compared to an average S&P500 Dividend Yield of 2.38, ARD has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.42%

5.2 History

The dividend of ARD is nicely growing with an annual growth rate of 12.62%!
ARD has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)12.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
ARD Yearly Dividends per shareARD Yearly Dividends per shareYearly Dividends per share 2017 2020 2021 0.5 1 1.5

5.3 Sustainability

ARD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of ARD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-2350%
EPS Next 2Y14.94%
EPS Next 3Y16.76%

More info and screens

Ardagh Group SA

NYSE:ARD (10/5/2021, 8:42:00 PM)

After market: 24.72 -0.03 (-0.12%)

24.75

+0.63 (+2.61%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A N/A
Earnings (Next)02-18 2022-02-18/bmo
Inst Owners0.01%
Inst Owner Change-48.09%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap461.83M
Analysts84
Price Target30.45 (23.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.42%
Yearly Dividend0.6
Dividend Growth(5Y)12.62%
DP-2350%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.66
Fwd PE 13.01
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 5.25
EPS(TTM)1.58
EY6.38%
EPS(NY)1.9
Fwd EY7.69%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS383.23
BVpS-14.15
TBVpSN/A
PEG (NY)1.58
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.05%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 6.03%
PM (TTM) -0.08%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity -34.8
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.77
Quick Ratio 2.3
Altman-Z 0.62
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.39%
EPS 3Y-6.97%
EPS 5YN/A
EPS Q2Q%21.62%
EPS Next Y9.94%
EPS Next 2Y14.94%
EPS Next 3Y16.76%
EPS Next 5Y17.94%
Revenue 1Y (TTM)9.39%
Revenue growth 3Y-7.83%
Revenue growth 5Y-1.05%
Sales Q2Q%16.69%
Revenue Next Year10.92%
Revenue Next 2Y8.75%
Revenue Next 3Y8.72%
Revenue Next 5Y8.07%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A